Volume 386, Issue 10006, Pages (November 2015)

Slides:



Advertisements
Similar presentations
Disclosure Statement of Financial Interest
Advertisements

Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Fractional Flow Reserve Versus Angiography for Guiding.
Volume 366, Issue 9481, Pages (July 2005)
Volume 14, Issue 12, Pages (November 2013)
Volume 370, Issue 9586, Pages (August 2007)
Severity of Coronary Arterial Stenoses Responsible for Acute Coronary Syndromes  Ganesh Manoharan, MD, Argyrios Ntalianis, MD, Olivier Muller, MD, PhD,
Volume 381, Issue 9872, Pages (March 2013)
Volume 385, Issue 9980, Pages (May 2015)
Volume 379, Issue 9824, Pages (April 2012)
Rationale and design of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) 3 Trial: A comparison of fractional flow reserve–guided.
Volume 12, Issue 11, Pages (October 2011)
Volume 385, Issue 9985, Pages (June 2015)
Previous coronary stents do not increase early and long-term adverse outcomes in patients undergoing off-pump coronary artery bypass grafting: A propensity-matched.
Volume 11, Issue 4, Pages (April 2012)
Volume 388, Issue 10058, Pages (November 2016)
Volume 378, Issue 9785, Pages (July 2011)
Volume 376, Issue 9734, Pages (July 2010)
Long-term effects of hormone replacement therapy
Volume 384, Issue 9957, Pages (November 2014)
Percutaneous coronary invervention versus coronary artery bypass grafting: A meta- analysis  Yolba Smit, MD, MSc, Joan Vlayen, MD, Hetty Koppenaal, MD,
Volume 11, Issue 6, Pages (June 2012)
Volume 384, Issue 9952, Pages (October 2014)
The impact of placing multiple grafts to each myocardial territory on long-term survival after coronary artery bypass grafting  Danny Chu, MD, Faisal.
Volume 376, Issue 9734, Pages (July 2010)
Long-term effects of hormone replacement therapy
Nat. Rev. Cardiol. doi: /nrcardio
Aspirin in the prevention of cancer – Author's reply
Volume 374, Issue 9707, Pages (December 2009)
Stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: A meta-analysis of comparative studies  Hisato Takagi,
J. Trevor Posenau, MD, Daniel M. Wojdyla, MS, Linda K
Value of Magnetic Resonance Imaging, Angiography, and Fractional Flow Reserve to Evaluate the Left Main Coronary Artery After Direct Surgical Angioplasty 
Volume 392, Issue 10141, Pages (July 2018)
Volume 384, Issue 9957, Pages (November 2014)
Volume 9, Issue 9, Pages (September 2010)
Meta-analysis of randomised controlled trials
Long-Term Survival of Patients With Ischemic Cardiomyopathy Treated by Coronary Artery Bypass Grafting Versus Medical Therapy  Eric J. Velazquez, MD,
Coronary artery bypass grafting is superior to first-generation drug-eluting stents for unprotected left main coronary artery disease: An updated meta-analysis.
Volume 379, Issue 9812, Pages (January 2012)
Volume 378, Issue 9785, Pages (July 2011)
Volume 383, Issue 9925, Pages (April 2014)
Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled.
Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris  Toshihiro Fukui,
Volume 14, Issue 11, Pages (October 2013)
Volume 385, Issue 9962, Pages (January 2015)
Volume 385, Issue 9985, Pages (June 2015)
Volume 388, Issue 10058, Pages (November 2016)
Hisato Takagi, MD, PhD, Hideaki Manabe, MD, Takuya Umemoto, MD, PhD 
Volume 371, Issue 9627, Pages (May 2008)
Volume 378, Issue 9786, Pages (July 2011)
Impact of statin therapy on patients with coronary heart disease and aortic aneurysm or dissection  Junichi Tazaki, MD, Takeshi Morimoto, MD, PhD, Ryuzo.
Volume 375, Issue 9726, Pages (May 2010)
Department of Error The Lancet Volume 369, Issue 9564, (March 2007)
Volume 373, Issue 9668, Pages (March 2009)
Volume 373, Issue 9658, Pages (January 2009)
Volume 375, Issue 9719, Pages (March 2010)
Volume 375, Issue 9714, Pages (February 2010)
Volume 373, Issue 9668, Pages (March 2009)
Cardiac risk in patients undergoing carotid endarterectomy: Impact on perioperative and long-term mortality  William C. Mackey, MD, Thomas F. O'Donnell,
Volume 12, Issue 8, Pages (August 2013)
ACST: which subgroups will benefit most from carotid endarterectomy?
MATCH Results: Implications for the Internist
Drug-eluting stents versus coronary artery bypass grafting for the treatment of coronary artery disease: A meta-analysis of randomized and nonrandomized.
Volume 14, Issue 9, Pages (August 2013)
Volume 13, Issue 7, Pages (July 2014)
Stent Versus Off-Pump Coronary Bypass Grafting in the Second-Generation Drug- Eluting Stent Era  Gijong Yi, MD, PhD, Hyun-Chel Joo, MD, Young-Nam Youn,
Figure 1 Design of trials included in individual patient data meta-analysis. Unless provided in the caption above, the following copyright applies to the.
Total Arterial Off-Pump Coronary Surgery: Time to Change Our Habits?
Volume 371, Issue 9617, Pages (March 2008)
Magnus Dalén, MD, Torbjörn Ivert, MD, PhD, Martin J
Presentation transcript:

Volume 386, Issue 10006, Pages 1853-1860 (November 2015) Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial  Lokien X van Nunen, MD, Frederik M Zimmermann, MD, Pim A L Tonino, PhD, Prof Emanuele Barbato, PhD, Prof Andreas Baumbach, MD, Thomas Engstrøm, PhD, Prof Volker Klauss, PhD, Prof Philip A MacCarthy, PhD, Ganesh Manoharan, MD, Prof Keith G Oldroyd, MD, Peter N Ver Lee, MD, Marcel van't Veer, PhD, Prof William F Fearon, MD, Bernard De Bruyne, PhD, Prof Nico H J Pijls, PhD  The Lancet  Volume 386, Issue 10006, Pages 1853-1860 (November 2015) DOI: 10.1016/S0140-6736(15)00057-4 Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 1 Trial profile PCI=percutaneous coronary intervention. The Lancet 2015 386, 1853-1860DOI: (10.1016/S0140-6736(15)00057-4) Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 2 Kaplan-Meier curves for survival free from major adverse cardiac events (A), all-cause mortality (B), all-cause mortality or myocardial infarction (C), and revascularisation (D) FFR=fractional flow reserve. PCI=percutaneous coronary intervention. The Lancet 2015 386, 1853-1860DOI: (10.1016/S0140-6736(15)00057-4) Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 3 Subgroup analyses of the primary endpoint major cardiac adverse events at 5 years Data are n/N (%), unless otherwise indicated. Relative risks (with 95% CI) of the primary endpoint are shown by subgroup. FFR=fractional flow reserve. PCI=percutaneous coronary intervention. The Lancet 2015 386, 1853-1860DOI: (10.1016/S0140-6736(15)00057-4) Copyright © 2015 Elsevier Ltd Terms and Conditions